Table 5 50 and 75 % responder rates comparison between MO and NMO patients
Outcome | Change | WMO, N (%) | MO, N (%) | P value |
|---|---|---|---|---|
Headache days | ≥50 % reduction | 55/215 (26 %) | 63/219 (29 %) | 0.46 |
≥75 % reduction | 24/215 (11 %) | 22/219 (10 %) | 0.71 | |
Migraine days | ≥50 % reduction | 99/215 (46 %) | 97/219 (44 %) | 0.71 |
≥75 % reduction | 14/215 (20 %) | 40/219 (18 %) | 0.56 | |
Painkiller days | ≥50 % reduction | 64/215 (30 %) | 94/219 (43 %) | 0.004 |
≥75 % reduction | 33/215 (15 %) | 44/219 (20 %) | 0.20 | |
Triptan days | ≥50 % reduction | 51/215 (24 %) | 67/219 (31 %) | 0.11 |
≥75 % reduction | 26/215 (12 %) | 32/219 (15 %) | 0.44 | |
Days off work | ≥50 % reduction | 28/43 (65 %) | 7/14 (50 %) | 0.31 |
≥75 % reduction | 19/43 (44 %) | 4/14 (29 %) | 0.30 | |
Crystal clear days | ≥2-fold increase | 83/215 (39 %) | 116/219 (54 %) | 0.003 |
≥3-fold increase | 46/215 (21 %) | 73/219 (33 %) | 0.005 |